Enterprise record

Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63fVersion: public-1As of: unavailable

24 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 30, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 30, 2026

    Supports 3 claims
    • Legal Name: Olema Pharmaceuticals, Inc. · Claim reviewed: Sep 30, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 30, 2026
    • Published Fact: US · Claim reviewed: Sep 30, 2026

  2. SEC DEF 14A 0001193125-26-191956

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 12, 2026

    Supports 12 claims
    • Leadership Role: Ian Clark: Chairperson of the Board · Claim reviewed: Sep 30, 2026
    • Leadership Role: Cyrus L. Harmon, Ph.D.: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Gorjan Hrustanovic, Ph.D.: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Graham Walmsley, M.D., Ph.D.: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Prakash Raman, Ph.D.: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Sandra Horning, M.D.: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Sean Bohen, M.D., Ph.D.: Director, President and Chief Executive Officer · Claim reviewed: Sep 30, 2026
    • Leadership Role: David C. Myles, Ph.D.: Chief Scientific Officer · Claim reviewed: Sep 30, 2026
    • Leadership Role: Naseem Zojwalla, M.D.: Chief Medical Officer · Claim reviewed: Sep 30, 2026
    • Leadership Role: Sean Bohen, M.D., Ph.D.: President and Chief Executive Officer · Claim reviewed: Sep 30, 2026
    • Leadership Role: Shane Kovacs: Chief Operating and Financial Officer · Claim reviewed: Sep 30, 2026
    • Leadership Role: Shawnte M. Mitchell, J.D.: Chief Legal Officer and Corporate Secretary · Claim reviewed: Sep 30, 2026

  3. DEF 14A olma-20260429.htm

    sec proxy · Source published: Apr 29, 2026 · Retrieved: Sep 2, 2026

    Supports 9 claims
    • Leadership Role: Andrew Rappaport: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Cynthia Butitta: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Cyrus L. Harmon: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Gorjan Hrustanovic: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Graham Walmsley: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Prakash Raman: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Sandra J. Horning: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Scott Garland: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Yi Larson: Director · Claim reviewed: Sep 30, 2026